Clinical Trials Logo

Constriction, Pathologic clinical trials

View clinical trials related to Constriction, Pathologic.

Filter by:

NCT ID: NCT01445171 Completed - Clinical trials for Aortic Valve Stenosis

Surgical Treatment of Aortic Stenosis With a Next Generation Surgical Aortic Valve

TRITON
Start date: January 2010
Phase: N/A
Study type: Interventional

The purpose of this clinical investigation is to confirm that the safety and performance of the EDWARDS INTUITY Valve System.

NCT ID: NCT01439620 Completed - Biliary Stricture Clinical Trials

Optical Frequency Domain Imaging (OFDI) for Biliary Stricture Imaging

Start date: February 2009
Phase: N/A
Study type: Interventional

The goal of this study is to evaluate the potential of comprehensive biliary Optical Frequency Domain Imaging (OFDI) for assessing common bile duct or common hepatic duct strictures, determining cholangiocarcinoma margins, and evaluating primary sclerosing cholangitis (PSC).

NCT ID: NCT01437098 Completed - Clinical trials for Aortic Valve Stenosis

Clinical Evaluation of MDT-2111 in Subjects With Symptomatic Severe Aortic Stenosis

Start date: October 2011
Phase: N/A
Study type: Interventional

The primary objective of the present trial is to demonstrate the effectiveness and safety of the MDT-2111 in the treatment of symptomatic severe aortic stenosis in subjects deemed difficult for surgical operation.

NCT ID: NCT01422044 Completed - Aortic Stenosis Clinical Trials

Risk Prediction in Aortic Stenosis

PREDICT-AS
Start date: September 2009
Phase: N/A
Study type: Observational

The purpose of this study is to test the prognostic value of autonomic markers in patients with aortic stenosis.

NCT ID: NCT01419015 Completed - Clinical trials for Aortic Valve Stenosis

PREVAIL-20J - Transfemoral Placement of 20mm Aortic Balloon Expandable Transcatheter Valve Trial

PREVAIL-20J
Start date: June 2011
Phase: N/A
Study type: Interventional

A single arm, prospective multicenter non-randomized pivotal clinical trial evaluating the 20mm Edwards SAPIEN XT™ transcatheter heart valve (model 9300TFX), NovaFlex™ transfemoral delivery system, and crimper accessories. The trial includes a premarket pivotal cohort to evaluate the system performance as well as a post market clinical follow-up phase involving long term follow-up of all patients to evaluate the safety of investigational devices up to 5 years.

NCT ID: NCT01412541 Completed - Clinical trials for Femoral Artery Occlusion

Moxy Drug Coated Balloon vs. Standard Balloon Angioplasty for the Treatment of Femoropopliteal Arteries

LEVANT 2
Start date: July 2011
Phase: N/A
Study type: Interventional

The purpose of the study is to demonstrate the superior efficacy and non-inferior safety of the Moxy Drug Coated Balloon by direct comparison to standard percutaneous transluminal angioplasty (PTA) catheter for treatment of stenosis of the femoropopliteal arteries.

NCT ID: NCT01406353 Completed - Clinical trials for Moderate Mitral Stenosis

Early Percutaneous Mitral Intervention in Asymptomatic Moderate Mitral Stenosis

MITIGATE
Start date: July 29, 2011
Phase: N/A
Study type: Interventional

Although percutaneous mitral commissurotomy (PMC) has been accepted as an effective treatment for symptomatic patients with moderate or severe mitral stenosis (MS), most asymptomatic patients are not candidates for PMC owing to the small but inherent procedure-related risks. Asymptomatic patients with MS show good survival rates up to 10 years, but there was a sudden deterioration precipitated by atrial fibrillation or embolism in half of the patients. Because the success rates of PMC were improved to more than 95% in ideal patients from highly selected centers and early PMC may decrease the occurrence of adverse events, such as atrial fibrillation or embolism, experienced centers tend to perform PMC at an early stage of disease. However, the potential benefits of early preemptive PMC in asymptomatic patients should be balanced against the real risks related to the procedure, and further studies of the efficacy of PMC in the prevention of embolism are necessary to extend its indications to asymptomatic patients. To the best of our knowledge, No randomized trials have been performed to ascertain the optimal timing of intervention in asymptomatic patients with significant MS. The early percutaneous MITral Intervention versus conventional manaGement in Asymptomatic moderate miTral stEnosis (MITIGATE) trial was designed to compare clinical outcomes of early intervention with those of a conventional management based on current guidelines in asymptomatic moderate mitral stenosis.

NCT ID: NCT01404728 Completed - Malignancies Clinical Trials

Longitudinal Evaluation Study of Vaginal Stenosis With and Without Pelvic Radiation Therapy

Start date: January 8, 2013
Phase: N/A
Study type: Observational

This study evaluates the effects of treatment with a vaginal dilator to reduce vaginal stenosis in women receiving pelvic radiation therapy for pelvic malignancies.

NCT ID: NCT01393067 Completed - Clinical trials for Stenosis of the Bilio-biliary Anastomosis After Orthotopic Liver Transplantation

cSEMS vs. NEPS in Stricture of Biliary Anastomosis After Liver Transplantation

Start date: March 2011
Phase: N/A
Study type: Interventional

Stenosis at the bilio-biliary anastomosis occurs in up to 30% of patients after orthotopic liver transplantation. This study compares endoscopic treatment with implantation of multiple plastic endoprostheses vs. use of a removable, covered self-expandable metal stent (cSEMS).

NCT ID: NCT01358513 Completed - Aortic Stenosis Clinical Trials

Role of Active Valvular Calcification and Inflammation in Patients With Aortic Stenosis

Start date: July 2010
Phase:
Study type: Observational

The aortic valve is the main outlet valve from the heart. This valve can become diseased and narrowed when it needs to be replaced with an artificial valve. Currently, this is the commonest reason for someone to undergo a heart valve operation in the UK. Unfortunately, there are no medical treatments that can prevent or delay the progression of this disease process. Here, the investigators propose to use new state-of-the-art imaging techniques to better understand the disease process so that the investigators can effectively design and assess potential new treatments. The ultimate aim is to stop this disease before patients need to have surgery. In addition the investigators believe this technique will allow us to predict the rate of progression of the disease